Kissei Pharmaceutical Co., Ltd. (4547.T)
JPY 3795.0
(0.0%)
JPY 3795.0
(0.0%)
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2023 | -44.16 Billion JPY | -80.96% |
| 2022 | -24.4 Billion JPY | 13.99% |
| 2021 | -28.37 Billion JPY | -51.62% |
| 2020 | -18.71 Billion JPY | 45.87% |
| 2019 | -34.57 Billion JPY | -52.76% |
| 2018 | -22.63 Billion JPY | -9.13% |
| 2017 | -20.73 Billion JPY | 12.32% |
| 2016 | -23.65 Billion JPY | -5.77% |
| 2015 | -22.36 Billion JPY | 6.68% |
| 2014 | -23.96 Billion JPY | 14.38% |
| 2013 | -27.98 Billion JPY | -37.11% |
| 2012 | -20.41 Billion JPY | -30.96% |
| 2011 | -15.58 Billion JPY | 18.06% |
| 2010 | -19.02 Billion JPY | 0.6% |
| 2009 | -19.13 Billion JPY | -41.15% |
| 2008 | -13.55 Billion JPY | -591.41% |
| 2007 | 2.75 Billion JPY | 114.74% |
| 2006 | -18.71 Billion JPY | -48.08% |
| 2005 | -12.63 Billion JPY | -8.32% |
| 2004 | -11.66 Billion JPY | 0.0% |
| Year | Net Debt | Net Debt Growth |
|---|---|---|
| 2024 Q2 | -25.18 Billion JPY | -17.6% |
| 2024 Q1 | -21.41 Billion JPY | 51.51% |
| 2023 Q4 | -44.16 Billion JPY | -138.48% |
| 2023 FY | -44.16 Billion JPY | -80.96% |
| 2023 Q3 | -18.51 Billion JPY | 18.94% |
| 2023 Q1 | -22.7 Billion JPY | 6.98% |
| 2023 Q2 | -22.84 Billion JPY | -0.63% |
| 2022 Q3 | -22.17 Billion JPY | 17.26% |
| 2022 Q4 | -24.4 Billion JPY | -10.06% |
| 2022 FY | -24.4 Billion JPY | 13.99% |
| 2022 Q1 | -24.26 Billion JPY | 14.5% |
| 2022 Q2 | -26.79 Billion JPY | -10.46% |
| 2021 FY | -28.37 Billion JPY | -51.62% |
| 2021 Q2 | -23.62 Billion JPY | -6.46% |
| 2021 Q4 | -28.37 Billion JPY | -70.62% |
| 2021 Q1 | -22.19 Billion JPY | -18.61% |
| 2021 Q3 | -16.62 Billion JPY | 29.62% |
| 2020 Q1 | -20.48 Billion JPY | 40.73% |
| 2020 Q4 | -18.71 Billion JPY | 12.57% |
| 2020 FY | -18.71 Billion JPY | 45.87% |
| 2020 Q2 | -23.35 Billion JPY | -13.97% |
| 2020 Q3 | -21.4 Billion JPY | 8.34% |
| 2019 Q1 | -27.71 Billion JPY | -22.47% |
| 2019 Q3 | -29.28 Billion JPY | 9.03% |
| 2019 Q4 | -34.57 Billion JPY | -18.06% |
| 2019 Q2 | -32.18 Billion JPY | -16.14% |
| 2019 FY | -34.57 Billion JPY | -52.76% |
| 2018 FY | -22.63 Billion JPY | -9.13% |
| 2018 Q4 | -22.63 Billion JPY | -14.16% |
| 2018 Q3 | -19.82 Billion JPY | 23.78% |
| 2018 Q1 | -22.32 Billion JPY | -7.65% |
| 2018 Q2 | -26.01 Billion JPY | -16.51% |
| 2017 Q3 | -21.77 Billion JPY | 9.87% |
| 2017 Q1 | -23.14 Billion JPY | 2.15% |
| 2017 Q4 | -20.73 Billion JPY | 4.74% |
| 2017 FY | -20.73 Billion JPY | 12.32% |
| 2017 Q2 | -24.15 Billion JPY | -4.36% |
| 2016 Q2 | -24.85 Billion JPY | -19.47% |
| 2016 Q3 | -19.74 Billion JPY | 20.55% |
| 2016 FY | -23.65 Billion JPY | -5.77% |
| 2016 Q1 | -20.8 Billion JPY | 6.98% |
| 2016 Q4 | -23.65 Billion JPY | -19.79% |
| 2015 Q3 | -16.92 Billion JPY | 16.83% |
| 2015 Q2 | -20.34 Billion JPY | -1.95% |
| 2015 Q1 | -19.95 Billion JPY | 16.71% |
| 2015 FY | -22.36 Billion JPY | 6.68% |
| 2015 Q4 | -22.36 Billion JPY | -32.14% |
| 2014 Q2 | -28.68 Billion JPY | -7.18% |
| 2014 Q3 | -18.63 Billion JPY | 35.04% |
| 2014 FY | -23.96 Billion JPY | 14.38% |
| 2014 Q4 | -23.96 Billion JPY | -28.63% |
| 2014 Q1 | -26.75 Billion JPY | 4.38% |
| 2013 Q1 | -21.58 Billion JPY | -5.73% |
| 2013 Q3 | -20.82 Billion JPY | 17.38% |
| 2013 Q4 | -27.98 Billion JPY | -34.38% |
| 2013 FY | -27.98 Billion JPY | -37.11% |
| 2013 Q2 | -25.2 Billion JPY | -16.8% |
| 2012 Q3 | -16.45 Billion JPY | 9.53% |
| 2012 Q2 | -18.19 Billion JPY | -5.69% |
| 2012 FY | -20.41 Billion JPY | -30.96% |
| 2012 Q1 | -17.21 Billion JPY | -10.43% |
| 2012 Q4 | -20.41 Billion JPY | -24.02% |
| 2011 FY | -15.58 Billion JPY | 18.06% |
| 2011 Q4 | -15.58 Billion JPY | -11.86% |
| 2011 Q2 | -16.84 Billion JPY | 13.4% |
| 2011 Q1 | -19.45 Billion JPY | -2.28% |
| 2011 Q3 | -13.93 Billion JPY | 17.3% |
| 2010 Q3 | -14.44 Billion JPY | 20.27% |
| 2010 FY | -19.02 Billion JPY | 0.6% |
| 2010 Q4 | -19.02 Billion JPY | -31.67% |
| 2010 Q2 | -18.12 Billion JPY | 6.71% |
| 2010 Q1 | -19.42 Billion JPY | -1.5% |
| 2009 Q3 | -16.57 Billion JPY | 7.74% |
| 2009 Q2 | -17.96 Billion JPY | 0.0% |
| 2009 FY | -19.13 Billion JPY | -41.15% |
| 2009 Q4 | -19.13 Billion JPY | -15.48% |
| 2008 Q3 | -7.44 Billion JPY | 0.0% |
| 2008 FY | -13.55 Billion JPY | -591.41% |
| 2008 Q4 | -13.55 Billion JPY | -82.06% |
| 2007 FY | 2.75 Billion JPY | 114.74% |
| 2006 FY | -18.71 Billion JPY | -48.08% |
| 2005 FY | -12.63 Billion JPY | -8.32% |
| 2004 FY | -11.66 Billion JPY | 0.0% |
| Name | Net Debt | Net Debt Difference |
|---|---|---|
| Pharma Foods International Co., Ltd. | 1.22 Billion JPY | 3704.898% |
| Takeda Pharmaceutical Company Limited | 4385.95 Billion JPY | 101.007% |
| Sumitomo Pharma Co., Ltd. | 389.83 Billion JPY | 111.328% |
| Shionogi & Co., Ltd. | -346.47 Billion JPY | 87.254% |
| Wakamoto Pharmaceutical Co.,Ltd. | -3.56 Billion JPY | -1139.016% |
| Nippon Shinyaku Co., Ltd. | -42.15 Billion JPY | -4.754% |
| Kaken Pharmaceutical Co., Ltd. | -61.47 Billion JPY | 28.165% |
| Eisai Co., Ltd. | -97.93 Billion JPY | 54.907% |
| Morishita Jintan Co., Ltd. | -667 Million JPY | -6520.69% |
| Hisamitsu Pharmaceutical Co., Inc. | -51.82 Billion JPY | 14.784% |
| Mochida Pharmaceutical Co., Ltd. | -32.92 Billion JPY | -34.139% |
| Fuso Pharmaceutical Industries,Ltd. | 7.6 Billion JPY | 680.9% |
| Nippon Chemiphar Co., Ltd. | 7.78 Billion JPY | 667.536% |
| Tsumura & Co. | 1.61 Billion JPY | 2834.365% |
| Torii Pharmaceutical Co., Ltd. | -34.43 Billion JPY | -28.234% |
| Towa Pharmaceutical Co., Ltd. | 172.7 Billion JPY | 125.569% |
| Fuji Pharma Co., Ltd. | 26.62 Billion JPY | 265.865% |
| Zeria Pharmaceutical Co., Ltd. | 28.98 Billion JPY | 252.372% |
| KYORIN Holdings, Inc. | 7.06 Billion JPY | 725.496% |
| Taiko Pharmaceutical Co.,Ltd. | 704 Million JPY | 6372.727% |
| Daito Pharmaceutical Co.,Ltd. | 5.99 Billion JPY | 836.983% |
| SymBio Pharmaceuticals Limited | -6.51 Billion JPY | -577.612% |
| MedRx Co., Ltd | -1.72 Billion JPY | -2467.442% |
| Mizuho Medy Co.,Ltd. | -8.71 Billion JPY | -406.627% |
| Solasia Pharma K.K. | -668 Million JPY | -6510.778% |
| Modalis Therapeutics Corporation | -1.47 Billion JPY | -2902.168% |
| ASKA Pharmaceutical Holdings Co.,Ltd. | -7.25 Billion JPY | -508.852% |
| Sawai Group Holdings Co., Ltd. | 56.52 Billion JPY | 178.129% |
| Cyfuse Biomedical K.K. | -2.96 Billion JPY | -1391.502% |
| Toho Holdings Co., Ltd. | -98.42 Billion JPY | 55.135% |
| Koa Shoji Holdings Co.,Ltd. | -11.12 Billion JPY | -296.78% |